- 米国企業
- Altimmune, Inc.
Altimmune, Inc.ALT
時価総額
$4.3億
PER
| 2011年 12月31日 | 2012年 12月31日 | 2013年 12月31日 | 2014年 12月31日 | 2015年 12月31日 | 2016年 12月31日 | 2017年 12月31日 | 2018年 12月31日 | 2019年 12月31日 | 2020年 12月31日 | 2021年 12月31日 | 2022年 12月31日 | |
| Revenues | 24 | - | - | - | - | - | 11 | 10 | 6 | 8 | 4 | -0 |
| Research and development | 21 | 20 | 15 | 9 | 5 | 5 | 18 | 18 | 18 | 50 | 75 | 71 |
| General and administrative | 14 | 12 | 13 | 11 | 6 | 12 | 8 | 10 | 9 | 13 | 15 | 17 |
| Impairment loss on construction-in-progress | - | - | - | - | - | - | - | - | - | - | 11 | - |
| Total operating expenses | 36 | 31 | 29 | 20 | 14 | 16 | 63 | 53 | 27 | 63 | 101 | 88 |
| Loss from operations | -11,725,731 | -6,266,390 | -10,839,208 | -10,191,305 | -3,402,800 | -11,264,347 | -52,045,259 | -42,834,410 | -21,464,935 | -54,798,741 | -96,914,041 | -88 |
| Interest expense | 54,573 | 342,561 | 369,281 | 210,399 | 54,581 | - | 162,139 | 297,090 | 2,244 | 9,421 | 5,656 | 0 |
| Interest income | 16,660 | 17,808 | 2,575 | - | - | - | 47,579 | 226,597 | 843,409 | 322,514 | 202,741 | 3 |
| Other income (expense), net | 39,328 | 47,862 | -6,071 | -762 | 8,137 | 7,847 | 5,670 | 277,886 | 15,139 | 24,147 | -373,868 | -0 |
| Total other income (expense), net | 8 | 2 | -817,399 | 297,656 | 23,841 | 216 | -18,506 | -2,486,536 | 886,304 | 337,240 | -176,783 | 3 |
| Net loss before income taxes | - | -4,724,586 | -11,656,607 | -9,893,649 | -3,378,959 | 205 | -52,063,765 | -45,320,946 | -20,578,631 | -54,461,501 | -97,090,824 | -85 |
| Income Tax Expense Benefit | - | - | - | 61,746 | 61,746 | 11 | -5,638,375 | -6,149,794 | -58,500 | -5,417,024 | - | -0 |
| Net loss | -3,797,573 | -4,920,115 | -11,718,353 | -9,955,395 | -3,440,705 | 194 | -46,425,390 | -39,171,152 | -20,520,131 | -49,044,477 | -97,090,824 | -85 |
| Other comprehensive income - unrealized (loss) gain on short-term investments | - | - | - | - | - | - | - | - | 20,007 | -24,361 | 4,354 | -0 |
| Comprehensive loss | - | - | - | - | - | - | - | - | -20,500,124 | -49,068,838 | -97,086,470 | -85 |
| Net loss per share, basic | - | - | - | - | - | 2.97 | - | - | - | - | -2.35 | -1.81 |
| Net loss per share, diluted | - | - | - | - | - | 2.95 | - | - | - | - | -2.35 | -1.81 |